NIH to evaluate remdesivir treatment for COVID during pregnancy
Por um escritor misterioso
Descrição
WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
SARS-CoV-2 infection in pregnancy: A systematic review and meta
COVID-19 in people with rheumatic diseases: risks, outcomes
Management of Patients With COVID-19
Oral Antivirals for High-Risk COVID-19 Patients
Outpatient Treatment Options for Acute COVID-19
Investigational Antivirals for Managing COVID-19
Remdesivir Now Approved for COVID Outpatients, Too
Remdesivir against COVID-19 and Other Viral Diseases
Phase III Trial to Study Combination of Genentech's Actemra
Remdesivir in pregnant women with moderate to severe coronavirus
:strip_icc()/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2019/r/0/A43KT8RNeClLHMgsALaA/lol-wild-rift-1.jpg)
